Navigating Aripiprazole Through Pregnancy: Balancing Psychiatric Stability and Fetal Exposure
Pregnancy introduces profound complexity into aripiprazole management, requiring clinicians and patients to weigh the documented risks of fetal medication exposure against the equally serious dangers of untreated psychiatric illness. Current research offers important—though incomplete—guidance on this difficult decision. This article synthesizes the available evidence to help patients and providers approach pre-conception planning with greater clarity.